BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11579815)

  • 1. New adjuvant therapies for esophageal cancer.
    Law S; Wong J
    Adv Surg; 2001; 35():271-95. PubMed ID: 11579815
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative chemoradiotherapy using taxanes for locally advanced esophageal carcinoma.
    Thirion P; Piedbois Y
    J Clin Oncol; 2001 Mar; 19(6):1880-2. PubMed ID: 11251021
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined modality therapy in esophageal cancer: the Memorial experience.
    Anderson SE; Minsky BD; Bains M; Kelsen DP; Ilson DH
    Semin Surg Oncol; 2003; 21(4):228-32. PubMed ID: 14648780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy for the patients with esophageal cancer].
    Ando N; Shih CH
    Nihon Geka Gakkai Zasshi; 2002 Apr; 103(4):359-63. PubMed ID: 11993225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection with and without chemotherapy in oesophageal cancer.
    Chander S
    Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387979
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress of postoperative adjuvant therapies for esophageal cancer].
    Terashima M; Kogure M; Gotoh M
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2475-80. PubMed ID: 12506469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced disease and new drugs.
    Frustaci S; Buonadonna A; La Mura N; Berretta M; De Paoli A
    Suppl Tumori; 2003; 2(5):S48-50. PubMed ID: 12914391
    [No Abstract]   [Full Text] [Related]  

  • 9. [Postoperative adjuvant therapies for esophageal carcinoma].
    Kuwano H; Ojima H; Kato H
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2023-7. PubMed ID: 11103232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer.
    Ajani JA; Faust J; Yao J; Komaki R; Stevens C; Swisher S; Putnam JB; Vaporciyan A; Smythe R; Walsh G; Rice D; Roth J
    Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):20-2. PubMed ID: 14569843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
    Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
    Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer.
    Kelsey CR; Chino JP; Willett CG; Clough RW; Hurwitz HI; Morse MA; Bendell JC; D'Amico TA; Czito BG
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):770-6. PubMed ID: 17889266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel in the treatment of esophageal cancer.
    Rigas JR; Dragnev KH; Bubis JA
    Semin Oncol; 2005 Apr; 32(2 Suppl 4):S39-51. PubMed ID: 16015553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Asian Perspective on the Surgical and Adjuvant Management of Esophagogastric Cancer.
    Kurokawa Y; Sasako M
    Surg Oncol Clin N Am; 2017 Apr; 26(2):213-224. PubMed ID: 28279465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complete response in a case of advanced esophageal cancer treated with docetaxel/5-FU/CDDPand S-1/docetaxel as neoadjuvant chemotherapy].
    Seike J; Matsuoka H; Yuasa Y; Yamai H; Yoshida T; Honda J; Miyoshi T; Tangoku A
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):633-6. PubMed ID: 18408433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan in esophageal cancer.
    Ilson DH; Minsky B
    Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):32-6. PubMed ID: 14569846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma.
    Urba SG; Orringer MB; Ianettonni M; Hayman JA; Satoru H
    Cancer; 2003 Nov; 98(10):2177-83. PubMed ID: 14601087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of esophageal cancer with multiple lymph node metastases which responded to neoadjuvant chemotherapy (DCF therapy).
    Shimakawa T; Naritaka Y; Asaka S; Isohata N; Yamaguchi K; Murayama M; Konno S; Katsube T; Ogawa K; Ide H
    Anticancer Res; 2010 Jan; 30(1):221-6. PubMed ID: 20150639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.